Back
Agios Pharmaceuticals Vs. United States Cellular Industry Stock Comparison
Buy
54
AGIO
Agios Pharmaceuticals
Last Price:
33.36
Seasonality Move:
-2.58%
Buy
71
USM
United States Cellular
Last Price:
44.12
Seasonality Move:
5.31%
Buy
54
Agios Pharmaceuticals (AGIO)
is a Buy
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $34.34. The Score for AGIO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- AGIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $34.34
The current trend is moderately bullish and AGIO is experiencing slight selling pressure.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
The current trend is moderately bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 62.73 | Buy |
| Chaikin Money Flow: | -280664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.37 - 34.23) | Buy |
| Bollinger Bands (100): | (24.08 - 32.34) | Buy |
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 133355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 42.71) | Buy |
| Bollinger Bands (100): | (34.57 - 42.69) | Buy |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.83 | Buy |
| 20-day SMA: | 33.07 | Buy |
| 50-day SMA: | 30.91 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 34.08 | Buy |
| 20-day EMA: | 33.02 | Buy |
| 50-day EMA: | 31.19 | Buy |
| 200-day EMA: | 27.51 | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.04 | Buy |
| 20-day SMA: | 39.26 | Buy |
| 50-day SMA: | 37.06 | Buy |
| 200-day SMA: | 40.1 | Buy |
| 8-day EMA: | 43.38 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 38.49 | Buy |
| 200-day EMA: | 36.73 | Buy |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.88 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Agios Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United States Cellular Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||